Ascendis Pharma A/S

Ascendis Pharma A/S

248.00
EUR
+4.00
(+1.64%)
13.36EPS
14.56P/E
13.25BMarket Cap
Feb 17Next Earn

Ascendis Pharma A/S Documents

Q1 FY2025 · Presentation

COACH Trial Interim Topline Week 26 Data - FINAL - 6.9.25 · 15 pages

Read Ascendis Pharma A/S's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2025 documents